Mother With Cancer Refused To Terminate Pregnancy, Despite Health Risk

Heidi Loughlin said she was diagnosed with a rare and fast-spreading form condition called inflammatory breast cancer in September 2015. She said the doctors told her she needed to undergo aggressive treatment using the drug Herceptin to stop the cancer from spreading. However, in able for them to proceed with the procedure, she needs to make a hard decision: the termination of her pregnancy.

But the 33- year-old mom chose to delay the treatment to give her child a chance to survive -- opting for a milder treatment instead. However, during the 27 weeks of her pregnancy, she was left with no option after doctors found out that her cancer was worsening.

Thus, she delivered her baby girl, Ally Louise 12 weeks early so she could start right away with the treatment. The child was born in December with 2lb 5ozs weighs. Everything seemed to be going well and the baby appeared to be healthy. However, five days later Heidi announced through her blog that her newborn daughter already passed away. Along with the message is a moving poem for her child.

"We kissed you, we cuddled you, we tickled your feet," the poem reads. "And I know again one day we'll meet."

Talking about her daughter's death, Loughlin told BBC that after her child died, she questioned the point of having chemotherapy. She said if she only knew that delivering her child too early would only be the cause of her death "I would have kept her in my tummy," the mother exclaimed.

"Everything was brilliant and then she got really, really unwell and wouldn't ever recover," the mother of two boys added. "It was the darkest most horrendous all-consuming feeling."

Loughlin said Ally's death is definitely unbearable, but her husband's "selfless" love is helping her to get through with it. She also admitted that she doesn't have any idea how long she has gotten left but she is trying to stay strong for her family.

© 2024 ParentHerald.com All rights reserved. Do not reproduce without permission.

Join the Discussion
Real Time Analytics